Home/Unity Biotechnology/Keith C. Leonard, Jr.
KC

Keith C. Leonard, Jr.

Chairman of the Board of Directors

Unity Biotechnology

Unity Biotechnology Pipeline

DrugIndicationPhase
UBX1325 (foselutoclax)Diabetic Macular Edema (DME)Phase 2b
UBX0101Osteoarthritis of the KneePhase 2
UBX1967Ophthalmology (Undisclosed)Preclinical
CNS ProgramsUndisclosed Neurological DiseasesDiscovery/Preclinical